Clinical Trials Directory

Trials / Conditions / Aggressive Lymphoma

Aggressive Lymphoma

7 registered clinical trials studyying Aggressive Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingEarly Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
NCT06485076
University Health Network, TorontoN/A
RecruitingMosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
NCT05412290
Washington University School of MedicinePhase 1
Active Not RecruitingNKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell
NCT05020678
Nkarta, Inc.Phase 1
TerminatedStudy of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocy
NCT04806035
TG Therapeutics, Inc.Phase 1
TerminatedA Study Of The Selective PKC-β Inhibitor MS- 553
NCT03492125
MingSight Pharmaceuticals, IncPhase 1 / Phase 2
CompletedRituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-ce
NCT01686321
University of GöttingenPhase 2
CompletedStudy to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL
NCT01562977
Grupo Español de Linfomas y Transplante Autólogo de Médula ÓseaPhase 2